Clinical Trial Update: Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A

View source ↗

Summary

This clinical trial update describes evaluating the effectiveness and long-term safety of damoctocog alfa pegol in people with Hemophilia A, sponsored by Bayer,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Damoctocog alfa pegol (damoctocog alfa pegol)

Snippet

Sponsor: Bayer | Conditions: Hemophilia A | Status: ACTIVE_NOT_RECRUITING